Literature DB >> 11143994

Angiotensin II as a mediator of tubulointerstitial injury.

G Wolf1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11143994     DOI： 10.1093/ndt/15.suppl_6.61

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  16 in total

Review 1.  Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?

Authors:  Ahmed Saad; Sandra M Herrmann; Stephen C Textor
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 2.  Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders.

Authors:  Mark A Perazella; John F Setaro
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  Involvement of the renin-angiotensin system in the development of nephrogenic systemic fibrosis-like lesions in the RenTag mouse model.

Authors:  Sandra Sexton; Ryan Tulowitzki; Craig A Jones; Silvi Shah; George Hajduczok; Kenneth W Gross; Mandip Panesar
Journal:  Clin Exp Nephrol       Date:  2015-07-03       Impact factor: 2.801

4.  Angiotensin II suppresses adenosine monophosphate-activated protein kinase of podocytes via angiotensin II type 1 receptor and mitogen-activated protein kinase signaling.

Authors:  Ji-Young Choi; Tae-Sun Ha; Hye-Young Park; Hee-Yul Ahn
Journal:  Clin Exp Nephrol       Date:  2012-06-20       Impact factor: 2.801

5.  Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.

Authors:  Miguel L Graciano; Kenneth D Mitchell
Journal:  Am J Physiol Renal Physiol       Date:  2011-10-05

6.  Effects of adaptive exercise on apoptosis in cells of rat renal tubuli.

Authors:  Marzena Podhorska-Okolow; Piotr Dziegiel; Eugenia Murawska-Cialowicz; Jolanta Saczko; Julita Kulbacka; Agnieszka Gomulkiewicz; Katia Rossini; Zbigniew Jethon; Ugo Carraro; Maciej Zabel
Journal:  Eur J Appl Physiol       Date:  2006-11-11       Impact factor: 3.078

7.  Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

Authors:  Miguel L Graciano; Akira Nishiyama; Keith Jackson; Dale M Seth; Rudy M Ortiz; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07

Review 8.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

Review 9.  Inflammation and Oxidative Damage in Ischaemic Renal Disease.

Authors:  Áine M de Bhailís; Constantina Chrysochou; Philip A Kalra
Journal:  Antioxidants (Basel)       Date:  2021-05-25

10.  Effect of the Direct Renin Inhibitor Aliskiren on Urinary Albumin Excretion in Spontaneous Type 2 Diabetic KK-A (y) Mouse.

Authors:  Masako Furukawa; Tomohito Gohda; Shinji Hagiwara; Mitsuo Tanimoto; Satoshi Horikoshi; Kazuhiko Funabiki; Yasuhiko Tomino
Journal:  Int J Nephrol       Date:  2013-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.